D-0599-2018 Class III Terminated
FDA drug recall D-0599-2018 was initiated by Novel Laboratories, Inc. on Mar 5, 2018 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Jun 8, 2020). Affected quantity: 134,364 bottles (4,030,920 tablets).
Recall details
- Product Type
- Drugs
- Report Date
- Mar 21, 2018
- Initiation Date
- Mar 5, 2018
- Termination Date
- Jun 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 134,364 bottles (4,030,920 tablets)
Product description
Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-118-03 UPC 343386118038
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide
Code information
M16002A (02/2018); M16246A (04/2018); M16246B (04/2018); M16434A (07/2018); M16569A (10/2018); M17015A (01/2019); S700271 (04/2019);
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0599-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026